Oral corticosteroids
Oral corticosteroids is a pharmaceutical drug with 13 clinical trials. Currently 2 active trials ongoing. Historical success rate of 62.5%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
3
Mid Stage
7
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
55.6%
5 of 9 finished
44.4%
4 ended early
2
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials
Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial
Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency
A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)
The Nationwide Real-world Status of Oral Corticosteroid Use in Patients With Asthma
Clinical Trials (13)
Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials
Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial
Clinical Study of DTX301 AAV-Mediated Gene Transfer for Ornithine Transcarbamylase (OTC) Deficiency
A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)
The Nationwide Real-world Status of Oral Corticosteroid Use in Patients With Asthma
Interest of Oral Corticosteroids in the Treatment of Chronic Subdural Hematomas
Effect of Adjuvant Hyperbaric Oxygen Therapy on Bells Palsy Outcome
Predicting Response to Standardized Pediatric Colitis Therapy
Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers
A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent
BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis
BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis
An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies
All 13 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 13